Summary Stage 2018: Hypopharynx

Summary Stage 2018

Notes

**Hypopharynx** 8000-8700, 9700-9701 C129-C132, C138-C139 C129 Pyriform sinus C130 Postcricoid region C131 Hypopharyngeal aspect of aryepiglottic fold C132 Posterior wall of hypopharynx C138 Overlapping lesion of hypopharynx C139 Hypopharynx, NOS (laryngopharynx) **Note 1:** The following sources were used in the development of this chapter * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 11 *Oropharynx (p16-) and Hypopharynx*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following chapters for the listed histologies * 8710-8714, 8800-8934, 8940-9137, 9141-9582: *Soft Tissue* * 8720-8790: *Melanoma Head and Neck* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma*" **Note 3:** Code 2 If there is fixation of hemilarynx or larynx.

NAACCR Item

NAACCR #764
SS2018 Description
0 In situ: noninvasive, intraepithelial
1 Localized only (localized, NOS) - Confined to hypopharynx - Laryngopharynx - Postcricoid area - Posterior pharyngeal wall - Pyriform fossa or sinus
2 Regional by direct extension only - Carotid artery (encased) - Central compartment soft tissues of neck including + Prelaryngeal strap muscle(s) + Subcutaneous fat - Cricoid cartilage - Esophagus - Extrinsic muscle of tongue - Fixation of structures in code 1 (localized with fixation) - Fixation of hemilarynx, larynx or oropharynx - Hard palate - Hemilarynx - Mandible - Medial pterygoid - Oropharynx - Prevertebral fascia/muscle(s) - Soft tissues of neck - Thyroid cartilage/gland
3 Regional lymph node(s) involved only - Level I + Level IA - Submental + Level IB - Submandibular (submaxillary), sublingual - Level II - Upper jugular + Jugulodigastric (subdigastric) + Upper deep cervical + Level IIA - Anterior + Level IIB - Posterior - Level III - Middle jugular + Middle deep cervical - Level IV - Lower jugular + Jugulo-omohyoid (supraomohyoid) + Lower deep cervical + Virchow node - Level V - Posterior triangle group + Posterior cervical + Level VA - Spinal accessory + Level VB - Transverse cervical, supraclavicular - Level VI - Anterior compartment group + Laterotracheal + Paralaryngeal + Paratracheal - above suprasternal notch + Perithyroidal + Precricoid (Delphian) + Prelaryngeal + Pretracheal - above suprasternal notch + Recurrent laryngeal - Level VII - Superior mediastinal group (for other mediastinal node(s) see code 7) + Esophageal groove + Paratracheal - below suprasternal notch + Pretracheal - below suprasternal notch - Other groups + Cervical, NOS + Deep cervical, NOS + Facial * Buccinator (buccal) * Mandibular * Nasolabial + Internal jugular, NOS + Parapharyngeal + Parotid * Infraauricular * Intraparotid * Periparotid * Preauricular + Retroauricular (mastoid) + Retropharyngeal + Suboccipital - Regional lymph node(s), NOS + Lymph node(s), NOS
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Base of tongue + Floor of tongue + Hyoid bone + Mediastinal structure(s) + Nasopharynx - Distant lymph node(s), NOS + Mediastinal (excluding superior mediastinal node(s)) - Distant metastasis, NOS + Carcinomatosis + Distant mets WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Lydiatt, W.M., Patel, S.G., Shah, J.P., et al. **Staging Head and Neck Cancers**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 55-65 (6) Lydiatt, W.M., Ridge, J.A., Shah, J.P., et al. **Oropharynx (p16-) and Hypopharynx**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 123-135